Navigation Links
Data from Multiple Clinical Trials of OrbusNeich's Genous™ Bio-engineered R Stent™ Demonstrate Safety and Effectiveness Across Challenging Patient Subsets as Presented at TCT 2010
Date:9/25/2010

nduces less neointimal hyperplasia than bare metal stents," said Professor Wojakowski.  "These data confirm that Genous is safe and effective in patients with ACS with no stent thrombosis."

Genous Bio-engineered R stent shows complete endothelialization in majority of patients at 30 days post-implantation.

Dr. Pasi Karjalainen, M.D., Ph.D., of the Satakunta Central Hospital in Pori, Finland, presented 30-day follow-up optical coherence tomography (OCT) evaluations from 13 patients treated with the Genous Bio-engineered Cobalt Chromium Stent. The findings showed:

  • Out of 2224 stent struts, 96 percent analyzed were completely covered at 30 days.

  • The Doppler assessment of coronary flow velocity (CFR) demonstrated a functional endothelium at 30 days in almost all patients.

Dr. Karjalainen commented, "The complete endothelialization at 30 days in patients treated with the Genous stent demonstrates the ability of the EPC capture technology to accelerate the body's natural healing process."

Al Novak, Chairman and CEO of OrbusNeich, added, "The extensive clinical data sets presented today further support the use of the Genous Bio-engineered R stent as a safe and effective treatment option in challenging cases."

The symposium, which was chaired by Professor Dr. Sigmund Silber, M.D., Ph.D., of the Kardiologische Klinik Dr Muller, Munich, also featured a presentation about OrbusNeich's next generation Combo™ Bio-engineered Sirolimus Eluting Stent (Combo Stent). Professor Michael Haude, M.D., of Medical Clinic I at the Lukaskrankenhaus in Neuss, Germany, presented "The Future in DES: Combo."

About Genous  

Genous is OrbusNeich's patented endothelial progenitor cell (EPC) capture technology that promotes the accelerated natural healing of the vessel wall after the implantation of blood-contact devi
'/>"/>

SOURCE OrbusNeich
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
2. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
3. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
4. Kosan Opens Registration Program for Lead Hsp90 Inhibitor, Tanespimycin, in Multiple Myeloma
5. Multiple NIH Phase 2 HIV Vaccine Trials Using Vicals Technology Produce Encouraging Results
6. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
7. Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma
8. TorreyPines Therapeutics Completes Phase I Multiple Dose Clinical Trial of NGX267, a Selective M1 Agonist for the Potential Treatment of Cognitive Impairment Associated with Schizophrenia
9. Pharmacopeia Announces Positive Results from Phase 1 Multiple Ascending Dose Study of PS433540 (DARA)
10. Phase III Clinical Trial in Newly Diagnosed Multiple Myeloma Stopped Early Due to Highly Significant Efficacy Advantage of VELCADE(R) (Bortezomib) for Injection Based Therapy Across All Endpoints
11. Velcura Therapeutics, Inc. Reports Positive Pre-IND Meeting With FDA and Plans Early Clinical Trials for New Drug to Treat Multiple Myeloma Bone Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... FLINT, Mich. , Dec. 24, 2014  Diplomat ... largest independent specialty pharmacy, is proud to announce ... and quality at Diplomat, will take office as the ... 2015. The formal induction ceremony will take place Feb. ... which will be held at the Renaissance Center in ...
(Date:12/24/2014)... and LONDON , December 24, ... industry are expected to grow at an average rate ... of value and volume. Hip, knee and spine surgeries ... while in emerging economies they have a lower penetration. ... challenging the use of composites. Non-metallic orthopedic devices have ...
(Date:12/24/2014)... 2014 Echo Therapeutics, Inc. (NASDAQ: ... on skin permeation, continuous glucose monitoring and associated ... has been appointed Chief Executive Officer effective ... 20 years of experience in the medical device, ... served as Vice President, Business Development, Otsuka Pharmaceuticals as ...
Breaking Medicine Technology:Diplomat's senior director of education and quality to be inducted as 2015 president of the Michigan Pharmacists Association 2Diplomat's senior director of education and quality to be inducted as 2015 president of the Michigan Pharmacists Association 3Use of Composites in Orthopedic Industry to Reach $596 Million by 2020 2Use of Composites in Orthopedic Industry to Reach $596 Million by 2020 3Echo Therapeutics Announces Scott W. Hollander as President & Chief Executive Officer 2Echo Therapeutics Announces Scott W. Hollander as President & Chief Executive Officer 3
... 2011 /PRNewswire-Asia/ -- ShangPharma Corporation (NYSE: SHP ... and biotechnology research and development outsourcing company, today announced ... shareholders held in Hong Kong today. ... proposed by the Company: 1. THAT ...
... Masimo (NASDAQ: MASI ) announced today that ... October 1, 2011, after the market closes on October 25, 2011. ... p.m. PT (4:30 p.m. ET) and will be hosted by Joe ... Executive Vice President and Chief Financial Officer. A live ...
Cached Medicine Technology:ShangPharma Corporation Announces Shareholder Resolutions Adopted at 2011 Annual General Meeting 2Masimo to Report Third Quarter 2011 Financial Results After Market Close on October 25, 2011 2Masimo to Report Third Quarter 2011 Financial Results After Market Close on October 25, 2011 3
(Date:12/25/2014)... 26, 2014 “Every three months the trends ... A-line sweetheart evening dress will be one of the hottest ... of Yunx.co.uk says. Today, the company releases 26 A-line sweetheart ... to 80% off. , “We are trying our best ... with our latest designs. Along with affordable prices, we provide ...
(Date:12/25/2014)... Angeles, CA (PRWEB) December 25, 2014 The ... Dolcemaschio was created in honor of a true 9/11 ... at two film festivals including the 24 hours of Nuremberg ... Festival in Bangladesh. , Actress, screenwriter and director ... helped produce this film together with her husband, Gregory ...
(Date:12/25/2014)... Woodland Hills, California (PRWEB) December 25, 2014 ... in her home in Woodland Hills, California after an ... Harris passed away on Christmas Eve evening in her ... battle with aggressive metastatic breast cancer. ... International for over forty years, she pioneered and championed ...
(Date:12/25/2014)... Dennis Thompson HealthDay Reporter ... with complex chronic illnesses can receive effective, less expensive care ... easy access to a team of dedicated health care professionals, ... become seriously ill and need either hospitalization or a trip ... enhanced medical home clinic at the University of Texas in ...
(Date:12/25/2014)... News) -- Among early stage breast cancer patients who ... one percent will eventually develop leukemia as a result ... finding comes from a review of more than 20,000 ... it suggests that the risk for developing treatment-related leukemia, ... thought. "The frequency of bone marrow cancers such ...
Breaking Medicine News(10 mins):Health News:The True 9/11 Hero Story “Color of Honor” Premieres in Germany and Bangladesh: Luciana Lagana Plays the Mother of the Lead and Co-Produces with Blaise Dolcemaschio. 2Health News:The True 9/11 Hero Story “Color of Honor” Premieres in Germany and Bangladesh: Luciana Lagana Plays the Mother of the Lead and Co-Produces with Blaise Dolcemaschio. 3Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 2Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 3Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 4Health News:Coordinated Care Through 'Medical Home' Best for Chronically Ill Kids: Study 2Health News:Coordinated Care Through 'Medical Home' Best for Chronically Ill Kids: Study 3Health News:Breast Cancer Chemo Tied to Small But Significant Leukemia Risk 2Health News:Breast Cancer Chemo Tied to Small But Significant Leukemia Risk 3
... A new study provides a novel theory for how ... Center researcher Orrin Devinsky, MD, performed an in-depth analysis ... a consistent pattern of injury to the frontal lobe ... deficits caused by these injuries to the right hemisphere, ...
... than three-quarters of young violent offenders interviewed in two poverty-stricken ... violent incident, a new study reveals. , About half of ... said they had a close friend who died in a ... violence may lead some inner-city youth to accept violence as ...
... & Johnson will host an analyst meeting at 8:30 ... discuss fourth-quarter and full-year 2008 financial results. The meeting ... Chief Executive Officer.Investors and other interested parties may access ... Company,s website at www.investor.jnj.com . , A webcast ...
... Born no larger than a ballpoint pen at birth, ... named the 2009 National Ambassador for the March of Dimes, ... Virginia, was born very early at 25 weeks, weighing less ... only a 5 percent chance of survival. During her five-month ...
... health care , , TUESDAY, Jan. 13 (HealthDay News) -- ... approach adulthood to ensure they receive proper health care as ... Peter Scal of the University of Minnesota, found only about ... such as obtaining health insurance after coming of age. This ...
... 13 Availity, LLC was recognized,as the 2008 ... at the eighth,annual Excellence in Employee Development Awards ... University of North Florida (UNF) Division of ... along with other award winners, at a luncheon ...
Cached Medicine News:Health News:Delusions associated with consistent pattern of brain injury 2Health News:Delusions associated with consistent pattern of brain injury 3Health News:Study: Most young violent offenders in two NYC neighborhoods have seen someone killed 2Health News:Study: Most young violent offenders in two NYC neighborhoods have seen someone killed 3Health News:Study: Most young violent offenders in two NYC neighborhoods have seen someone killed 4Health News:Micro-Preemie Survives to Become March of Dimes 2009 National Ambassador 2Health News:Micro-Preemie Survives to Become March of Dimes 2009 National Ambassador 3Health News:Availity Achieves Excellence in Blended Learning Award 2
Auto refractometer....
A system with integrated pupil camera and 7" examination monitor. An easy to use configuration....
... The Selecta II Glaucoma Laser System features ... patients with open-angle glaucoma. It selectively targets ... intraocular pressure. The Selecta II is equipped ... high-energy beam of light, which induces the ...
Round handle....
Medicine Products: